---
title: "603998.SH (603998.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603998.SH/news.md"
symbol: "603998.SH"
name: "603998.SH"
parent: "https://longbridge.com/en/quote/603998.SH.md"
datetime: "2026-05-21T10:44:03.020Z"
locales:
  - [en](https://longbridge.com/en/quote/603998.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603998.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603998.SH/news.md)
---

# 603998.SH (603998.SH) — Related News

### [Fangsheng Pharmaceutical: Some products are planned to be selected for the centralized bulk purchasing of the National Traditional Chinese Medicine Procurement Alliance](https://longbridge.com/en/news/285347278.md)
*2026-05-06T09:33:03.000Z*
> Fangsheng Pharmaceutical and its wholly-owned subsidiary Jiangxi Tengwangge Pharmaceutical participated in the national 

### [Fangsheng Co., Ltd.: Net profit of 3.502 million yuan in the first quarter of 2026, a year-on-year decrease of 50.08%](https://longbridge.com/en/news/284547494.md)
*2026-04-29T10:33:52.000Z*
> Fangsheng Co., Ltd. announced that in the first quarter of 2026, the operating revenue was 81.7793 million yuan, an incr

### [Fangsheng Pharmaceutical: Net profit of 88.3917 million yuan in the first quarter of 2026, a year-on-year increase of 0.15%](https://longbridge.com/en/news/283993777.md)
*2026-04-24T11:41:25.000Z*
> Fangsheng Pharmaceutical announced that its revenue for the first quarter of 2026 was 463 million yuan, a year-on-year i

### [Fangsheng Pharmaceutical: Silaigang Tablets have obtained the "Drug Registration Certificate"](https://longbridge.com/en/news/280135182.md)
*2026-03-23T09:40:06.000Z*
> Fangsheng Pharmaceutical announced that the company's developed Selexipag tablets have obtained the drug approval number

### [Fangsheng Pharmaceutical: Bisoprolol Amlodipine Tablets have obtained the drug registration certificate](https://longbridge.com/en/news/277746752.md)
*2026-03-04T08:27:02.000Z*
> Fangsheng Pharmaceutical announced that its wholly-owned subsidiary Jianmeng Pharmaceutical obtained the drug registrati

### [Fangsheng Pharmaceutical's selected products will continue procurement after the expiration of the centralized procurement agreement](https://longbridge.com/en/news/277436222.md)
*2026-03-02T09:17:26.000Z*
> Fangsheng Pharmaceutical announced that the company will participate in the continuation procurement of the first to eig

### [Fangsheng Pharmaceutical: Holding subsidiary obtains "Drug Manufacturing License"](https://longbridge.com/en/news/274934692.md)
*2026-02-05T07:53:35.000Z*
> Fangsheng Pharmaceutical announced that its holding subsidiary, Guangdong Fangsheng Ronghua Pharmaceutical Co., Ltd., ha

### [Innovative drug concept stocks rise, Cosunter up over 13%](https://longbridge.com/en/news/274906499.md)
*2026-02-05T03:11:12.000Z*
> On the morning of February 5th, innovative drug concept stocks surged, with Cosunter rising over 13%, followed by Fangsh